NCT06634030 2026-03-23Evaluating rhPDGF-BB-Enhanced Wound Matrix for Head and Neck ReconstructionVanderbilt University Medical CenterPhase 2 Recruiting40 enrolled
NCT00518102 2016-07-19The Risk of Cancer in Users of Regranex (Becaplermin) and Matched Comparators (Nonusers of Regranex [Becaplermin])Ethicon, Inc.Completed4,431 enrolled